147 related articles for article (PubMed ID: 17973210)
21. Long-acting insulin analogues (insulin glargine or determir) and continuous subcutaneous insulin infusion in the treatment of type 1 diabetes mellitus in the paediatric population.
Barrio Castellanos R
J Pediatr Endocrinol Metab; 2005 Dec; 18 Suppl 1():1173-9. PubMed ID: 16398447
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes.
Weinzimer SA; Ternand C; Howard C; Chang CT; Becker DJ; Laffel LM;
Diabetes Care; 2008 Feb; 31(2):210-5. PubMed ID: 17989308
[TBL] [Abstract][Full Text] [Related]
23. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.
Pańkowska E; Szypowska A; Lipka M; Szpotańska M; Błazik M; Groele L
Pediatr Diabetes; 2009 Aug; 10(5):298-303. PubMed ID: 19175902
[TBL] [Abstract][Full Text] [Related]
24. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
25. Lower dose basal insulin infusion has positive effect on glycaemic control for children with type I diabetes on continuous subcutaneous insulin infusion therapy.
Schulten RJ; Piet J; Bruijning PC; de Waal WJ
Pediatr Diabetes; 2017 Feb; 18(1):45-50. PubMed ID: 26880282
[TBL] [Abstract][Full Text] [Related]
26. Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German/Austrian DPV registry.
Grammes J; Küstner E; Dapp A; Hummel M; Kämmer JC; Kubiak T; Schütz-Fuhrmann I; Zimny S; Bollow E; Holl RW;
Diabet Med; 2020 May; 37(5):856-862. PubMed ID: 31853984
[TBL] [Abstract][Full Text] [Related]
27. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.
Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R
Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965
[TBL] [Abstract][Full Text] [Related]
28. Treatment and long-term follow-up of patients diagnosed with type 1 diabetes mellitus before age 5.
Ata A; Er E; Evin F; Işıklar H; Abdullayev N; Demir G; Özen S; Altınok YA; Darcan Ş; Gökşen D
J Pediatr Endocrinol Metab; 2021 Feb; 34(2):201-207. PubMed ID: 33544547
[TBL] [Abstract][Full Text] [Related]
29. A Pilot Study of Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults with Type 1 Diabetes (FIRST1D).
Rilstone S; Reddy M; Oliver N
J Diabetes Sci Technol; 2021 May; 15(3):666-671. PubMed ID: 32081036
[TBL] [Abstract][Full Text] [Related]
30. Predicting the optimal basal insulin infusion pattern in children and adolescents on insulin pumps.
Holterhus PM; Bokelmann J; Riepe F; Heidtmann B; Wagner V; Rami-Merhar B; Kapellen T; Raile K; Quester W; Holl RW;
Diabetes Care; 2013 Jun; 36(6):1507-11. PubMed ID: 23404300
[TBL] [Abstract][Full Text] [Related]
31. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
Bolli GB; Kerr D; Thomas R; Torlone E; Sola-Gazagnes A; Vitacolonna E; Selam JL; Home PD
Diabetes Care; 2009 Jul; 32(7):1170-6. PubMed ID: 19389820
[TBL] [Abstract][Full Text] [Related]
32. Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study.
Lepore G; Dodesini AR; Nosari I; Trevisan R
Diabetes Nutr Metab; 2004 Apr; 17(2):84-9. PubMed ID: 15244099
[TBL] [Abstract][Full Text] [Related]
33. Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy.
Raile K; Noelle V; Landgraf R; Schwarz HP
J Pediatr Endocrinol Metab; 2002 May; 15(5):607-12. PubMed ID: 12014519
[TBL] [Abstract][Full Text] [Related]
34. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
[TBL] [Abstract][Full Text] [Related]
35. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
Willi SM; Planton J; Egede L; Schwarz S
J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
[TBL] [Abstract][Full Text] [Related]
36. Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial.
Bragd J; von Döbeln A; Lins PE; Adamson U; Bergström J; Oskarsson P
Diabetes Technol Ther; 2010 Sep; 12(9):689-93. PubMed ID: 20687863
[TBL] [Abstract][Full Text] [Related]
37. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.
Danne T; Battelino T; Kordonouri O; Hanas R; Klinkert C; Ludvigsson J; Barrio R; Aebi C; Gschwend S; Mullis PE; Schumacher U; Zumsteg U; Morandi A; Rabbone I; Cherubini V; Toni S; de Beaufort C; Hindmarsh P; Sumner A; van Waarde WM; van den Berg N; Phillip M
Pediatr Diabetes; 2005 Dec; 6(4):193-8. PubMed ID: 16390387
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Continuous Subcutaneous Insulin Infusion Pump Therapy During Five Years of Treatment on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus.
Korkmaz Ö; Demir G; Çetin H; Mecidov İ; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):147-152. PubMed ID: 29537377
[TBL] [Abstract][Full Text] [Related]
39. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
Hirsch IB; Bode BW; Garg S; Lane WS; Sussman A; Hu P; Santiago OM; Kolaczynski JW;
Diabetes Care; 2005 Mar; 28(3):533-8. PubMed ID: 15735183
[TBL] [Abstract][Full Text] [Related]
40. Failure of glycated hemoglobin drop after continuous subcutaneous insulin infusion initiation may indicate patients who discontinue: a 4-year follow-up study in children and adolescents with type 1 diabetes.
Lombardo F; Scaramuzza AE; Iafusco D
Acta Diabetol; 2012 Dec; 49 Suppl 1():S99-105. PubMed ID: 22008950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
